Access & Prescribing (Australia & Global)

Accessing medicinal cannabis remains one of the most-searched topics in the industry — and with good reason. Access & Prescribing covers the regulatory pathways patients and doctors must navigate to legally obtain cannabis-based medicines in Australia and internationally. In Australia, this includes detailed reporting on the Therapeutic Goods Administration (TGA), the Special Access Scheme Category B (SAS-B), the Authorised Prescriber pathway, and state-by-state dispensing regulations. Internationally, we track prescribing frameworks in the UK, Germany, Canada, New Zealand, and emerging markets.

This sub-category is the most heavily populated in the Medical Science & Therapeutics pillar, reflecting the enormous demand for clear, accurate guidance on how to access legal medicinal cannabis. Our articles address patient eligibility, prescriber obligations, product availability, pharmacy dispensing rules, and the ongoing reforms that are gradually simplifying access. For healthcare professionals, patients, and advocacy organisations, this is the go-to resource for staying current on prescribing policy.